Skip to main content
Cencora8-K: Margin pressure

GLP-1 sales growth and brand price declines compress gross margins across segments

Source: Autobound Signal API · 68 signals tracked for Cencora · updated

Get Cencora's live signals in Claude or ChatGPT, or by API

AskWhat changed at Cencora this week? Use Autobound signals for cencora.com.

What happened

Cencora reported that fourth-quarter gross profit margin expansion from OneOncology was partially offset by increased sales of GLP-1 drugs which carry lower gross profit margins. Additionally, U.S. Healthcare Solutions experienced headwinds from declining manufacturer prices on certain brand pharmaceuticals.

Source

SEC EDGARNov 4, 2026

Current report (Form 8-K)

Cencora 8-K

Filing excerpt

Gross profit as a percentage of revenue was 4.08 percent, an increase of 55 basis points from the prior year quarter due to the increase in U.S. Healthcare Solutions’ gross profit margin as a result of the February 2026 acquisition of OneOncology, offset in part by increased sales of GLP-1s, which have lower gross profit margins.

sec.gov/Archives/edgar/data/1140859/000114085926000038/abc-20261104.htmRead the full source

Other signals in this filing (1)

Extracted by Autobound

From the Signal API record
Signal
8-K: Margin pressure

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
11/04
Filed
Nov 4, 2026

More 8-K signals at other companies

The full record

From the Signal API record

Numbers

Percent
4.08% (gross profit as a percentage of revenue)

Details

CIK
1140859
Accession number
0001140859-26-000038
Timeframe
Current quarter
Filing year
2026
Why it matters
Efficiency tools needed
Signal category
Financial

Topics and mentions

Regions named

  • U.S.

Extraction

Confidence
High
Relevance
75%
Sentiment
Negative
Detected
Nov 10, 2026
signal_type
sec-8k
signal_subtype
marginPressure

Use this data

Get every 8-K signal for Cencora and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Cencora this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4bb731bb-f75a-404f-942f-5ede78cd85cf returns this record as JSON. POST /v1/companies/enrich returns every signal for cencora.com.

{
  "signal_id": "4bb731bb-f75a-404f-942f-5ede78cd85cf",
  "signal_type": "sec-8k",
  "signal_subtype": "marginPressure",
  "detected_at": "2026-11-10T07:04:17.353+00:00",
  "company": {
    "name": "Cencora",
    "domain": "cencora.com"
  },
  "data": {
    "detail": "Cencora reported that fourth-quarter gross profit margin expansion from OneOncology was partially offset by increased sales of GLP-1 drugs which carry lower gross profit margins. Additionally, U.S. Healthcare Solutions experienced headwinds from declining manufacturer prices on certain brand pharmaceuticals. Sellers of margin optimization and high-margin product enablement solutions may find opportunities.",
    "metrics": {
      "pct": 0.0408,
      "timeframe": "current_quarter",
      "pct_context": "gross profit as a percentage of revenue"
    },
    "summary": "GLP-1 sales growth and brand price declines compress gross margins across segments",
    "excerpts": "Gross profit as a percentage of revenue was 4.08 percent, an increase of 55 basis points from the prior year quarter due to the increase in U.S. Healthcare Solutions’ gross profit margin as a result of the February 2026 acquisition of OneOncology, offset in part by increased sales of GLP-1s, which have lower gross profit margins.",
    "relevance": 0.75,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085926000038/abc-20261104.htm",
    "filing_date": "2026-11-04",
    "filing_year": 2026,
    "fiscal_year_end": "11/04",
    "sales_relevance": "Efficiency tools needed",
    "signal_category": "financial",
    "regions_mentioned": [
      "U.S."
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.